What are side effects associated with Celebrex?
Of the Celebrex treated patients in controlled trials, approximately 4,250 were patients with OA, approximately 2,100 were patients with RA, and approximately 1,050 were patients with post-surgical pain. More than 8,500 patients have received a total daily dose of Celebrex of 200 mg (100 mg BID or 200 mg QD) or more, including more than 400 treated at 800 mg (400 mg BID). Approximately 3,900 patients have received Celebrex at these doses for 6 months or more; approximately 2,300 of these have received it for 1 year or more and 124 of these have received it for 2 years or more. Adverse events from controlled trials: Table 1 lists all adverse events, regardless of causality, occurring in >=2% of patients receiving Celebrex from 12 controlled studies conducted in patients with OA or RA that included a placebo and/or a positive control group.
